N-(2-(Indolin-1-yl)phenyl)pyrazine-2-carboxamide

Catalog No. :
ACURKH075
CAS No. :
1100121-56-9
Molecular Formula :
C19H16N4O
Molecular Weight :
316.36

IUPAC Name:N-(2-(indolin-1-yl)phenyl)pyrazine-2-carboxamide

N-(2-(Indolin-1-yl)phenyl)pyrazine-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$155.00Login to see priceInquiryInquiry
50mg98%$265.00Login to see priceInquiryInquiry
100mg98%$449.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-(Indolin-1-yl)phenyl)pyrazine-2-carboxamide
IUPAC NameN-(2-(indolin-1-yl)phenyl)pyrazine-2-carboxamide
Molecular FormulaC19H16N4O
Molecular Weight316.36
SMILESO=C(C1=NC=CN=C1)NC2=CC=CC=C2N3CCC4=C3C=CC=C4
InChI KeyQLHRBUAVJBTERX-UHFFFAOYSA-N
Synonym2-Pyrazinecarboxamide, N-[2-(2,3-dihydro-1H-indol-1-yl)phenyl]-;N-(2-(Indolin-1-yl)phenyl)pyrazine-2-carboxamide;N-[2-(2,3-Dihydro-1H-indol-1-yl)phenyl]-2-pyrazinecarboxamide
CAS No.1100121-56-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACURKH075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZXFO064 route compound structure diagram
    ACZXFO06498-97-5 In Stock
  4. Then
  5. ACURKH075 route product structure diagram
    ACURKH0751100121-56-9 In Stock
Inquiry

2. ACURKH075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJKSV956 route compound structure diagram
    ACJKSV95619847-10-0 In Stock
  4. Then
  5. ACURKH075 route product structure diagram
    ACURKH0751100121-56-9 In Stock
Inquiry

Comments (0)